DNA methylation age is not accelerated in brain or blood of subjects with schizophrenia
暂无分享,去创建一个
Ying Ding | Robert A. Sweet | David A. Lewis | D. Lewis | R. Sweet | Ying Ding | B. McKinney | Huang Lin | Brandon C. McKinney | Huang Lin | D. Lewis
[1] B. Kirkpatrick,et al. Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naïve patients with nonaffective psychosis , 2017, Schizophrenia Research.
[2] J. Kleinman,et al. Reliability of psychiatric diagnosis in postmortem research , 2005, Biological Psychiatry.
[3] Robin M. Murray,et al. An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation , 2016, Genome Biology.
[4] S. Thiagalingam,et al. Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post‐mortem brain of patients with schizophrenia and Psychotic bipolar disorder , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[5] S. Horvath,et al. DNA methylation age of blood predicts all-cause mortality in later life , 2015, Genome Biology.
[6] D. Jeste,et al. Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia. , 2011, Schizophrenia bulletin.
[7] Steve Horvath,et al. Accelerated epigenetic aging in Down syndrome , 2015, Aging cell.
[8] O. Okusaga. Accelerated aging in schizophrenia patients: the potential role of oxidative stress. , 2014, Aging and disease.
[9] S. Saha,et al. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? , 2007, Archives of general psychiatry.
[10] M. First,et al. Structured clinical interview for DSM-IV axis II personality disorders : SCID-II , 1997 .
[11] I. Nazareth,et al. Physical activity, dietary habits and Coronary Heart Disease risk factor knowledge amongst people with severe mental illness , 2007, Social Psychiatry and Psychiatric Epidemiology.
[12] Etienne Sibille,et al. Brain molecular aging, promotion of neurological disease and modulation by Sirtuin5 longevity gene polymorphism , 2011, Neurobiology of Disease.
[13] J. Kleinman,et al. Critical Factors in Gene Expression in Postmortem Human Brain: Focus on Studies in Schizophrenia , 2006, Biological Psychiatry.
[14] P. Pan,et al. Shorter leukocyte telomere length in patients at ultra high risk for psychosis , 2017, European Neuropsychopharmacology.
[15] S. Horvath,et al. HIV-1 Infection Accelerates Age According to the Epigenetic Clock , 2015, The Journal of infectious diseases.
[16] M. Heo,et al. The distribution of body mass index among individuals with and without schizophrenia. , 1999, The Journal of clinical psychiatry.
[17] R. Sweet,et al. Dendritic spine alterations in schizophrenia , 2015, Neuroscience Letters.
[18] B. Laufer,et al. DNA methylation in psychosis: insights into etiology and treatment. , 2015, Epigenomics.
[19] Philip D. Harvey,et al. Is schizophrenia a syndrome of accelerated aging? , 2008, Schizophrenia bulletin.
[20] O. Wolkowitz,et al. Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging , 2015, Neuroscience & Biobehavioral Reviews.
[21] Daniel R Weinberger,et al. Mapping DNA methylation across development, genotype, and schizophrenia in the human frontal cortex , 2015, Nature Neuroscience.
[22] S. Horvath. DNA methylation age of human tissues and cell types , 2013, Genome Biology.
[23] Wei Zhang,et al. Reduced Dendritic Spine Density in Auditory Cortex of Subjects with Schizophrenia , 2009, Neuropsychopharmacology.
[24] S. Horvath,et al. Huntington's disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels , 2016, Aging.
[25] P. Mortensen,et al. Excess early mortality in schizophrenia. , 2014, Annual review of clinical psychology.
[26] T. Prolla. Multiple roads to the aging phenotype: insights from the molecular dissection of progerias through DNA microarray analysis , 2005, Mechanisms of Ageing and Development.
[27] Andres Metspalu,et al. The transcriptional landscape of age in human peripheral blood , 2015, Nature Communications.
[28] David A Lewis,et al. Schizophrenia as a disorder of neurodevelopment. , 2002, Annual review of neuroscience.
[29] R. Marioni,et al. The epigenetic clock and telomere length are independently associated with chronological age and mortality , 2016, International journal of epidemiology.
[30] H. Kraemer,et al. Elevated plasma F2-isoprostane levels in schizophrenia , 2016, Schizophrenia Research.
[31] D. Jeste,et al. Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables. , 2017, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[32] A. Sampson,et al. Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia , 2015, Biological Psychiatry.
[33] O. Howes,et al. Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis , 2017, JAMA psychiatry.
[34] C. Crombie,et al. A threonine to isoleucine missense mutation in the pericentriolar material 1 gene is strongly associated with schizophrenia , 2010, Molecular Psychiatry.
[35] A. Farmer,et al. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. , 1991, Archives of general psychiatry.
[36] J. Endicott,et al. Schedule for Affective Disorders and Schizophrenia , 2014 .
[37] D. Lewis,et al. Dendritic spine pathology in schizophrenia , 2013, Neuroscience.
[38] H. Kraemer,et al. Leukocyte telomere length: Effects of schizophrenia, age, and gender. , 2017, Journal of psychiatric research.
[39] P. Fitzgerald,et al. Superior temporal gyrus volume change in schizophrenia: A review on Region of Interest volumetric studies , 2009, Brain Research Reviews.
[40] M. Levine,et al. DNA methylation-based measures of biological age: meta-analysis predicting time to death , 2016, Aging.
[41] J. Birtwistle,et al. The unhealthy lifestyle of people with schizophrenia , 1999, Psychological Medicine.
[42] S. Horvath,et al. Decreased epigenetic age of PBMCs from Italian semi-supercentenarians and their offspring , 2015, Aging.
[43] Evgeny Putin,et al. Deep biomarkers of human aging: Application of deep neural networks to biomarker development , 2016, Aging.
[44] P. Visscher,et al. Rare chromosomal deletions and duplications increase risk of schizophrenia , 2008, Nature.
[45] J. Mill,et al. Schizophrenia-associated methylomic variation: molecular signatures of disease and polygenic risk burden across multiple brain regions , 2016, Human molecular genetics.
[46] O. Wolkowitz,et al. The Association Between Psychiatric Disorders and Telomere Length: A Meta-Analysis Involving 14,827 Persons , 2016, Psychosomatic medicine.
[47] M. Pato,et al. Using consensus OPCRIT diagnoses , 1999, British Journal of Psychiatry.
[48] D. Henderson,et al. Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses. , 2015, The lancet. Psychiatry.
[49] Alan C. Evans,et al. Changes in cortical thickness during the course of illness in schizophrenia. , 2011, Archives of general psychiatry.